D. Aksoy Et Al. , "Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy," Clinical Psychopharmacology and Neuroscience , vol.14, no.1, pp.74-78, 2016
Aksoy, D. Et Al. 2016. Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy. Clinical Psychopharmacology and Neuroscience , vol.14, no.1 , 74-78.
Aksoy, D., Güveli, B. T., Ak, P. D., SARI, H., Atakli, D., & Arpaci, B., (2016). Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy. Clinical Psychopharmacology and Neuroscience , vol.14, no.1, 74-78.
Aksoy, Duygu Et Al. "Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy," Clinical Psychopharmacology and Neuroscience , vol.14, no.1, 74-78, 2016
Aksoy, Duygu Et Al. "Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy." Clinical Psychopharmacology and Neuroscience , vol.14, no.1, pp.74-78, 2016
Aksoy, D. Et Al. (2016) . "Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy." Clinical Psychopharmacology and Neuroscience , vol.14, no.1, pp.74-78.
@article{article, author={Duygu Aksoy Et Al. }, title={Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy}, journal={Clinical Psychopharmacology and Neuroscience}, year=2016, pages={74-78} }